1. Introduction {#s0005}
===============

Most mental disorders are characterized by a high risk of recurrence or chronic courses ([@bb0495]; [@bb0515]; [@bb0680]). Short- and long-term recurrence rates for common mental disorders such as 21% to 55% for eating disorders ([@bb0445]; [@bb0500]), 40% for generalized anxiety disorder ([@bb0680]) or up to 85% for depression ([@bb0350]) have been reported. Adverse implications of chronicity and recurrence include an increased risk for comorbid somatic diseases ([@bb0185]; [@bb0520]), early retirement ([@bb0470]), a reduced quality of life ([@bb0585]) and elevated mortality ([@bb0320]).

Therefore, tertiary prevention aims to reduce symptom severity or disability, to promote functioning and quality of life and to identify, prevent and cope with recurrence or rehospitalization ([@bb0085]; [@bb0670]). Tertiary prevention thus plays an essential role in the intermediate or continuous care of mental disorders. It can be delivered through various forms, such as pharmacological or psychosocial treatments, medical or occupational rehabilitation, as aftercare, follow-up or maintenance treatment. A key sector of tertiary prevention is the post-discharge transition period following acute care, in which convalescents face various challenges regarding the transfer, adoption, and stabilization of health behavior changes and are confronted with individual, social or occupational difficulties ([@bb0075]). Extensive research has documented a heightened risk of relapse or rehospitalization in the first months after acute treatment ([@bb0235]; [@bb0500]; [@bb0640]). Risk factors include individual aspects (e.g. residual symptoms, compliance to treatment), implementation of and access to aftercare services, or contextual factors such as proximity to services or social support ([@bb0325]).

Meta-analytic evidence indicates the effectiveness of aftercare for mental disorders including psychotherapy ([@bb0090]; [@bb0640]), psychosocial interventions ([@bb0065]; [@bb0575]), pharmacological maintenance treatment ([@bb0200]) or psychosomatic rehabilitation ([@bb0600]) in reducing symptom severity, recurrence and in promoting functionality or treatment compliance ([@bb0020]; [@bb0430]).

However, although chronicity and recurrence of mental disorders represent a significant societal and economic burden ([@bb0645]), the effectiveness and implementation of aftercare instruments in routine care are limited for various reasons: reduced adoption of and compliance with aftercare services ([@bb0335]; [@bb0415]; [@bb0460]; [@bb0530]), organizational barriers such as long waiting times, limited local or temporal accessibility or pessimistic treatment expectancies ([@bb0570]; [@bb0580]), as well as insufficient prescription or initiation by clinicians ([@bb0160]; [@bb0375]; [@bb0580]). Eventually, limited resources of healthcare systems and high medical cost of aftercare services further impede their widespread implementation ([@bb0005]; [@bb0370]).

In an effort to reduce the threshold to health care utilization and to improve care along health sectors, Internet- and mobile-based interventions (IMIs) have been developed extensively, in particular within the last decade. IMIs can be administered cost-effectively ([@bb0510]) and may represent widely accessible instruments of tertiary prevention regarding increasing Internet access and use ([@bb0295]). IMIs may vary with regard to intervention strategy (e.g. monitoring, psychoeducation, behavior-change), technical implementation (e.g. mobile phone- app, website), localization in the healthcare process (e.g. prevention, stand-alone interventions, blended- or aftercare), or in their amount of human support ([@bb0150]). Guidance may range from self-administered or automated interventions (unguided) over varying intensity of human support through personalized feedback or contact with online-coaches up to regular synchronous contact, mirroring face-to-face therapy ([@bb0480]).

Evidence from several meta-analytic studies suggests the effectiveness of psychological IMIs as stand-alone interventions for a broad spectrum of mental disorders in adults such as affective and anxiety disorders ([@bb0340]; [@bb0505]), posttraumatic stress disorder (PTSD) ([@bb0400]), eating disorders ([@bb0245]) or chronic pain ([@bb0155]). With regard to the prevention of mental disorders, a recent meta-analysis of eight studies by [@bb0550] found a small effect size for IMIs in the primary prevention of depression (standardized mean difference, *SMD* = 0.35). However, the evidence for the effectiveness of IMIs in the primary prevention of further mental disorders is still limited and inconsistent ([@bb0145]).

Previous research on Internet- or mobile-based aftercare focused on guided, web- or mobile based self-help, mirroring existing treatment rationales in modular, interactive treatment elements, combined with a certain amount of asynchronous (written) therapist contact ([@bb0135]; [@bb0685]). Others investigated mobile-based ([@bb0555]) or rather synchronous, chat- or video-based aftercare ([@bb0040]; [@bb0180]), highlighting the broad spectrum of implementation of IMIs in tertiary prevention. A growing body of research indicates the applicability of IMIs in tertiary prevention of chronic or recurrent mental disorders ([@bb0030]; [@bb0290]) and as step-down interventions after inpatient treatment for eating disorders ([@bb0045]; [@bb0220]), depression ([@bb0280]; [@bb0555]) or transdiagnostic approaches ([@bb0040]; [@bb0135]).

Hence, the purpose of this article is to systematically review the literature regarding the application of IMIs as aftercare or follow-up interventions for adults with mental health issues, to draw conclusions about their efficacy and to outline future directions for research and implementation into routine care.

2. Method {#s0010}
=========

2.1. Registration and study protocol {#s0015}
------------------------------------

This systematic review was reported according to the guidelines of the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" (PRISMA) ([@bb0405]), see [Appendix A](#ec0005){ref-type="supplementary-material"} and was registered in the international prospective register of systematic reviews (PROSPERO: CRD42017055289). The methodical procedure is described in detail in a correspondant study protocol ([@bb0265]).

2.2. Eligibility criteria {#s0020}
-------------------------

Studies were eligible for inclusion if they (a) focused on adults (≥18 years), who (b) have received treatment for a mental disorder or a somatic condition with comorbid mental symptoms within the previous six months on average. Mental disorder or clinical symptoms under study needed to be assessed with (c) standardized or validated instruments. Only (d) randomized controlled trials (RCTs) that were available in full text and published in English or German language were taken into consideration. Interventions under study should have been based on (e) distinguishable clinical-psychological elements and rationales, as described by [@bb0330], and implemented as (f) aftercare or follow-up interventions. Interventions needed to be provided (g) predominantly in an online setting (web- or mobile -based) and (h) report a minimum follow-up assessment of the main outcome of three months. Mandatory control groups (CG) (i) could be active (e.g. attention control website, treatment as usual (TAU), other treatment) or inactive (e.g. waiting list or no treatment).

2.3. Search strategy and study selection {#s0025}
----------------------------------------

A systematic search in three electronic databases (Medline, PsycInfo, Cochrane Central Register of Controlled trials, CENTRAL) was conducted in March 2018, based on a sensitive search term (see [Appendix B](#ec0010){ref-type="supplementary-material"}). Furthermore, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) was hand searched to identify ongoing trials. In addition, we examined reference lists of included publications. Study authors were contacted in case of unclear eligibility, unpublished or missing data and if no succeeding publication could be retrieved for published study protocols.

Two independent researchers \[SH, SF\] screened titles and abstracts of retrieved studies to identify eligible studies in a first step. In a second step, full texts of these studies were screened against eligibility criteria. Disagreement at both stages was resolved through discussion and consultation of a third researcher \[LS\].

2.4. Data extraction {#s0030}
--------------------

The following data were extracted from each study: (a) study identification items, (b) study design characteristics, (c) intervention characteristics, (d) technical characteristics, (e) type of mental disorder or clinical symptom to be treated, (f) target population items, (g) setting, (h) treatment engagement, (i) assessment of additional outcome variables, and (j) clinical outcome.

Regarding the latter, inspected outcomes were: symptom severity, symptom recurrence or incidence rate of mental disorder under study, rehospitalization rate, indicators of functionality or quality of life and adherence to primary treatment (e.g. medication compliance) from post-treatment to latest available follow-up. Follow-up periods up to 6 months were categorized as 'short', 6 to 12 months as 'medium' and beyond as 'long-term', as adapted from previous research ([@bb0550]). A second reviewer \[SH\] reexamined the extraction process and quality assessment to control for an investigator bias.

2.5. Evaluation of methodological quality {#s0035}
-----------------------------------------

The methodological quality of each study was analyzed according to the of Cochrane Risk of Bias tool ([@bb0270]) in the following domains: (1) selection bias, (2) performance and detection bias, (3) attrition and reporting bias, including incomplete outcome data and availability of intention-to-treat analysis. For guided interventions, thresholds for acceptable dropout rates were determined as ≤20% for short-term, ≤ 30% for medium and ≤ 35% for long-term follow-up periods and up to 40% for unguided interventions based on average dropout rates reported in previous reviews ([@bb0455]; [@bb0535]; [@bb0550]; [@bb0625]). Other threats to validity (4) included assessment of co-interventions, similar groups at baseline, intervention compliance, and identical timing for outcome assessments. Each domain was rated as having a 'low', 'unclear' or 'high' risk of bias according to the abovementioned criteria. Above that, the cumulative quality of evidence on the predefined outcomes was rated according to the 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)' ([@bb0230]) (see [Appendix C](#ec0015){ref-type="supplementary-material"}). Dimensions of the GRADE rating included (a) study limitations, (b) inconsistency of results, (c) indirectness of evidence, and (d) imprecision of effect estimates reporting bias. Evidence was graded following guidelines from the Cochrane Collaboration and supported by a checklist by [@bb0450] into 'very low', 'low', 'moderate', or 'high'.

2.6. Data analyses {#s0040}
------------------

Outcome variables were differentiated in terms of 'short', 'medium' or 'long-term' efficacy according to follow-up classification. For continuous outcomes (e.g. symptom severity), standardized effect sizes were calculated for the between-group comparison at the respective follow-up. Dichotomous outcomes (e.g. recurrence, rehospitalization) were transformed into odds or risk ratios (OR, RR). Because of the considerable heterogeneity of intervention, diagnostic and clinical characteristics of the included studies, meta-analytic pooling of effect sizes was not feasible. Furthermore, possible publication biases could not be estimated, due to the limited number of studies per outcome. However, mixed sample sizes, significant and non-significant effects reported may indicate a low risk for publication bias.

3. Results {#s0045}
==========

3.1. Study selection {#s0050}
--------------------

The database search provided a total of 2576 results. After removing duplicates, screening titles, abstracts and full-texts against inclusion criteria, a complementary hand search of trial registers, reference lists of eligible studies and contacting study authors, a total of 16 studies were included in this review. [Fig. 1](#f0005){ref-type="fig"} illustrates the search and selection process and reasons for exclusion according to the PRISMA-guidelines.Fig. 1PRISMA flow chart of study inclusion process.Fig. 1

3.2. Data extraction {#s0055}
--------------------

### 3.2.1. Overview {#s0060}

Included studies mainly targeted the tertiary prevention of depression (*n* = 5) and eating disorders (*n* = 4) or were designed as transdiagnostic interventions (*n* = 7), including aftercare for comorbid mental symptoms of somatic disorders. For three studies on eating disorders in an adolescent target population ([@bb0175]; [@bb0220]; [@bb0310]), we were able to retrieve unpublished age-stratified data of adult participants provided by study authors.

### 3.2.2. Intervention characteristics {#s0065}

The majority of interventions (*n* = 11) were based on principles of Cognitive Behavioral Therapy (CBT). One study ([@bb0070]) was based on general psychotherapy ([@bb0210]), two studies on psychodynamic ([@bb0690]; [@bb0695]) and one on mindfulness-based cognitive therapy (MBCT) ([@bb0395]) or focused on disease management ([@bb0620]). Eleven IMIs were web- and 5 predominantly mobile-based. Most interventions (*n* = 11) included some form of human support, all based on a written communication or additional phone contact. Five interventions were unguided ([@bb0070]; [@bb0395]; [@bb0620]; [@bb0660]; [@bb0700]). Intensity and mode of contact with participants varied across studies, including (semi-) automated pre-formulated messages or reminders to participants ([@bb0045]; [@bb0390]; [@bb0395]) or individual, monthly to weekly forms of human support through written feedback in the majority of interventions (see [Table 1](#t0005){ref-type="table"}). Here, guidance was provided by various occupational groups (e.g. research assistants, psychotherapists, clinical psychologists, nurses). Six studies provided an online or phone crisis management system ([@bb0045]; [@bb0135]; [@bb0175]; [@bb0220]; [@bb0280]; [@bb0390]). Interventions differed regarding the sequence of intervention elements with consecutive ([@bb0175]; [@bb0280]; [@bb0695]) or flexible order ([@bb0485]; [@bb0660]).Table 1Study characteristics.Table 1Study\
\[country\]Program nameTarget Disorder/symptomTarget\
populationIntervention type\
\[duration\]ConditionInstrumentsFollow-upStudy dropout[a](#tf0005){ref-type="table-fn"}[@bb0045][b](#tf0010){ref-type="table-fn"}\
\[Germany\]\[SMS-BRIDGE\]Bulimia Nervosa (BN) or Eating disorder not otherwise specified (EDNOS)Female adults, at least two episodes of binge eating a week for minimum of one month, after inpatient psychosomatic treatmentCBT\
Mobile-based; guided\
SMS-based weekly self-monitoring + semi-automated supportive feedback\
\[16 weeks\]IG: SMS-BRIDGE (*n* = 82)\
\
CG: TAU\
(*n* = 83)LIFE\
EDI-2\
SEED8 monthsIG: 13.4%\
CG: 16.9%[@bb0310]\
\
\[Germany\]IN\@BNFemale adolescents (≥ 17 yrs)[c](#tf0015){ref-type="table-fn"} after inpatient psychosomatic treatmentCBT\
Web-based; guided\
Active website; monitoring log + body image + personal diary + weekly feedback (e-mail) and individual chat (on demand)\
\[9 months\]IG: IN@ (*n* = 122)\
\
CG: TAU (*n* = 122)SIAB-EX9/18 monthsIG: 38.8%\
CG: 31.2%[@bb0220]\
\
\[Hungary\]EDINA[d](#tf0020){ref-type="table-fn"}BN or\
EDNOSFemale adolescents (≥ 16 yrs)[c](#tf0015){ref-type="table-fn"} after inpatient psychosomatic treatmentCBT\
Web-based; guided\
Psychoeducational online platform + weekly peer/individual chat (on demand)\
\[4 months\]IG: EDINA\
(*n* = 50)\
\
CG: TAU\
(*n* = 51)EDE-Q\
DASS-214 monthsIG: 32.0%\
CG: 21.6%[@bb0175][e](#tf0025){ref-type="table-fn"}\
\[Germany\]VIA[f](#tf0030){ref-type="table-fn"}Anorexia Nervosa (AN)Female adults (≥16 yrs)[c](#tf0015){ref-type="table-fn"} after inpatient treatmentCBT\
Web-based; guided\
Active website for relapse prevention + moderated monthly peer chat + contact on demand\
\[9 months\]IG: VIA\
(*n* = 113)\
\
CG: TAU\
(*n* = 117)SIAB-EX\
MROAS\
EDI-2\
BIS-11\
BSI9/18 monthsIG: 5.3%\
CG: 6.0%[g](#tf0035){ref-type="table-fn"}[@bb0695]\
\[Germany\]KEN[h](#tf0040){ref-type="table-fn"}TransdiagnosticAdults after inpatient/day-clinic psychosomatic treatmentPsychodynamic\
Web-based; guided\
Active website with affect-focused/mindfulness exercises + individual encouraging feedback on homework\
\[10 weeks\]IG: KEN\
(*n* = 42)\
\
CG = Waiting list (*n* = 40)ERSQ\
PHQ-9\
GAD-7\
EUROHIS-QOL\
RSE\
SSS-8\
CDS-2\
SPE10/18/20 weeks[i](#tf0045){ref-type="table-fn"}IG: 38.1%\
CG: 37.5%[@bb0070]\
\
\[Germany\]E-COACHTransdiagnosticFormerly employed adults after inpatient psychosomatic rehabilitation with excessive work-related self-demandsGeneral psychotherapy\
Mobile-based; unguided\
Self-monitoring + daily automated feedback\
\[6 months (2 weekly intervention phases)\]IG: E-COACH\
(*n* = 158)\
\
CG: Intention therapy\
(*n* = 121)AVEM\
SSI-K3\
MUM\
Health-4912 monthsIG: 63.9%\
CG: 64.5%[@bb0135]\
\
\[Germany\]TIMT[j](#tf0050){ref-type="table-fn"}TransdiagnosticAdults after inpatient psychosomatic treatmentCBT\
Web-based; guided\
Personal development plan + self-monitoring + web diary + peer support + weekly individual feedback on web-diary\
\[3 months\]IG: TIMT + TAU\
(*n* = 200)\
\
CG: TAU\
(*n* = 200)Health-49\
PANAS\
SEK-2712 monthsIG: 34.5% CG: 27.0%[@bb0690]\
\[Germany\]GSA-ONLINE[k](#tf0055){ref-type="table-fn"}TransdiagnosticFormerly employed patients (18--59 yrs) after inpatient cardiologic, psychosomatic/ orthopedic rehabilitationPsychodynamic\
Web-based; guided\
Weekly expressive writing + individual feedback\
\[3 months\]IG: GSA-ONLINE\
(*n* = 319)\
\
CG: Placebo website\
(*n* = 345)PHQ-9\
PHQ-15\
PHQ-10\
SF-12\
GAD-7\
AVEM-446 monthsIG: 32.0%\
CG: 30.4%[@bb0620]\
\[Finland\]MOBILE.NETTansdiagnosticAdults (18--65 yrs) after inpatient psychiatric treatment, continuing antipsychotic medicationSelf-determination theory\
Mobile-based; unguided\
self-selected, automated SMS to support treatment adherence/functioning\
\[12 months\]IG: MOBILE.NET\
(*n* = 569)\
\
CG: TAU\
(*n* = 570)CSQ-8\
Q-LES-Q GAS12 monthsIG: 52.9%\
CG: 54.0%[m](#tf0065){ref-type="table-fn"}[@bb0280][l](#tf0060){ref-type="table-fn"}\
\[Sweden\]iCBT[n](#tf0070){ref-type="table-fn"}Major Depression Disorder (MDD)Adults after previous psychotherapy/pharmacological therapy, ≥ 1 MDD in the last 5 years, in remission at recruitmentCBT\
Web-based; guided\
Active-website + individual feedback to weekly homework\
\[10 weeks\]IG: iCBT\
(*n* = 42)\
\
CG: Generic e-mail support on demand\
(*n* = 42)MADRS-S\
SCID-I\
BDI-II\
BAI\
WHOQOL-BREF6/12/24 monthsIG: 23.8%\
CG: 16.7%[@bb0390]\
\[Germany\]SUMMIT/\
SUMMIT-PERSON[o](#tf0075){ref-type="table-fn"}Recurrent MDDAdults (18--65 yrs) after inpatient treatment for depression, ≥ 3 previous depressive episodesCBT\
Web-based; guided\
Self-monitoring + crisis management plan + self-management skills, automated supportive feedback + moderated peer forum (SUMMIT-PERSON: + monthly peer/individual chat)\
\[12 months\]IG~1~: SUMMIT + TAU\
(*n* = 77)\
\
IG~2~: SUMMIT-PERSON + TAU\
(*n* = 79)\
\
CG: TAU\
(*n* = 80)LIFE6/12/18/24 monthsIG~1~: 16.9%\
IG~2~: 17.7%\
CG: 18.8%[@bb0700]\
\[Germany\]DEPREXISDepression,\
adjustment\
disorderAdults (18--65 yrs) after inpatient psychodynamic treatment for depressionCBT\
Web-based; unguided\
Active website + simulated dialogues in consecutive self-help modules\
\[3 months\]IG: DEPREXIS\
(*n* = 115)\
\
CG: placebo website (*n* = 114)BDI-II\
PHQ-9\
GAD-7\
RSE\
EUROHIS-QOL\
WAI\
HAQ\
DAS3 monthsIG: 26.1%\
CG: 25.4%[@bb0555]\
\
\[Germany\]eATROSDepressionAdults with (partially) remitted depression after inpatient psychosomatic rehabilitationCBT\
Mobile- based; guided\
Daily activity structuring/evaluation + relaxation exercises + stimulation of euthymic activities + medication plan + emergency strategies + standardized feedback (via phone on demand)\
\[3 months, 3 active phases\]IG: eATROS\
(*n* = 81)\
\
CG: TAU\
(*n* = 64)SSI-K3\
BDI3 monthsIG: 42.0%\
CG: 34.4%[@bb0395]\
\
\[Germany\]MIND-S[p](#tf0080){ref-type="table-fn"}DepressionAdults (18--75 yrs) after mindfulness group sessions in inpatient psychiatric treatmentMindfulness-based cognitive therapy (MBCT)\
Mobile-based; unguided\
SMS monitoring of mindfulness exercise + weekly reinforcing feedback\
\[4 months\]IG: MIND-S + TAU (*n* = 70)\
\
CG: TAU\
(*n* = 70)PHQ-9\
PTQ\
FFA-14\
SCS-D4 monthsIG: 14.3%\
CG: 15.0%[@bb0660][q](#tf0085){ref-type="table-fn"}\
\[Netherlands\]KNW[r](#tf0090){ref-type="table-fn"}Cancer diagnosis with comorbid anxiety/depression/fatigueAdults after primary treatment for cancer without signs of recurrencePST-/CBT\
Web-based; unguided\
Self-management training for fatigue, anxiety, and depression\
\[6 months\]IG: KNW\
(*n* = 253)\
\
CG: Waitinglist + TAU\
(*n* = 265)HADS\
CIS\
EORTC QLQ-C30\
global health status scale, functional scales\
(self-con-structed)3/6/12 monthsIG: 16.2%\
CG: 36.2%[@bb0485]\
\
\[Sweden\]U-CARE HeartMyocardial infarction (MI) with comorbid depression and anxietyAdult inpatients (\< 75 years) with MI within last three monthsCBT\
Web- and mobile-based; guided\
Tailored online-platform; psychoeducation + assignments + library (videos, supplementary material) + discussion board + weekly feedback (e-mail)\
\[14 weeks\]CG: TAU (*n* = 122)\
IG: U-CARE (*n* = 117)HADS\
MADRS-S\
BADS-SF\
CAQ14 weeksIG: 17.9%\
CG: 5.7%[^1][^2][^3][^4][^5][^6][^7][^8][^9][^10][^11][^12][^13][^14][^15][^16][^17][^18]

### 3.2.3. Study characteristics {#s0070}

In the sixteen included studies, a total of 4680 adults participated. Study dropout varied between 5.6% ([@bb0175]) and 64.2% ([@bb0070]) with an average of 26.3%. About two third of the studies included passive CGs, one-third active CGs ([@bb0070]; [@bb0280]; [@bb0690]; [@bb0700]). The majority of studies (*n* = 10) reported at least a medium follow-up period (6--12 months). Six studies reported a short (\<6 months) ([@bb0220]; [@bb0395]; [@bb0485]; [@bb0555]; [@bb0695]; [@bb0700]), and four studies a long-term follow-up period (\>12 months) ([@bb0180]; [@bb0285]; [@bb0310]; [@bb0390]). [Table 1](#t0005){ref-type="table"} provides an overview of relevant characteristics of included studies ordered by the diagnostic focus of the studies (for a list of abbreviations of instruments, see [Appendix D](#ec0020){ref-type="supplementary-material"}).

3.3. Mental disorders and symptoms {#s0075}
----------------------------------

### 3.3.1. Eating disorders {#s0080}

Four studies targeted eating disorders in a female, mostly adolescent population. [@bb0175] investigated an IMI for anorexia nervosa (AN), the other three studies examined the efficacy of an IMI for bulimia nervosa (BN) or eating disorders, not otherwise specified (EDNOS) ([@bb0045]; [@bb0220]; [@bb0310]). All interventions were CBT-based and provided some form of human guidance. The web-based program VIA ([@bb0175]) was based on well-established treatment manuals for anorexia and related disorders ([@bb0195]; [@bb0300], [@bb0305]). The intervention used common CBT techniques such as cognitive restructuring, behavioral analysis, stimulus control and action plans to prevent relapse after inpatient treatment. This included psychoeducational information, a web-diary on body-related and eating behaviors, exercises, symptom monitoring and optional therapist moderated monthly group chats. The *SMS-BRIDGE* by [@bb0045] investigated the efficacy of a 4-months text messaging intervention for the relapse prevention and symptom reduction of BN and EDNOS. Participants indicated bulimic symptoms weekly and received a tailored, semi-automated feedback including reinforcement of self-management strategies. The 4-months, web-based program *EDINA* ([@bb0220]) was developed as a step-down intervention to maintain treatment gains and to prevent relapse in BN and EDNOS. Guidance was provided through weekly moderated chat-groups of 5--8 participants, on-demand individual therapist contact and a monitoring and feedback system. The 9-months intervention *IN@* ([@bb0310]) used a similar therapeutic rationale for adolescents with BN following inpatient treatment with 11 lectures including symptom monitoring and a diary that was commented on by therapists and on-demand individual live-chats.

### 3.3.2. Depression {#s0085}

The search yield five studies on CBT-based aftercare or follow-up interventions for depression ([@bb0280]; [@bb0390]; [@bb0395]; [@bb0555]; [@bb0700]). Three interventions were therapist-guided and two unguided ([@bb0395]; [@bb0700]). The 10-week Swedish intervention by [@bb0280] focused on preventing relapse by treating residual symptoms and developing preventive strategies. Participants worked through web-based self-help material (e.g. behavioral activation, cognitive restructuring and relapse prevention) and received personalized feedback regarding homework and prompts when inactive. The web-based, 12-month program *SUMMIT* ([@bb0390]) focused on maintaining a remissive state of depression through symptom monitoring, an individual crisis management plan, psychoeducation and reinforcement of self-management strategies. *SUMMIT* included automated, pre-formulated feedback on symptom monitoring, whereas the variation *SUMMIT-PERSON* provided additional guidance through a monthly expert group or individual chat in case of symptom deterioration. The guided 3-months intervention *eATROS* by [@bb0555] included three active phases with degrading intensity based on an intermittent reinforcement of self-management. Core elements comprised activity structuring, relaxation exercises, a crisis management plan and guidance by an online-coach. Participants were asked to plan, structure and evaluate daily activities based on CBT-techniques and received standardized supportive feedback. Additional telephone-contact to the online-coach was available on demand and in case of critical health issues. The unguided, web-based program *DEPREXIS* was implemented as blended- and aftercare ([@bb0700]) following inpatient psychosomatic treatment. Program use was initiated during inpatient psychosomatic treatment and was continued for 3 months after discharge. Using automated and simulated dialogues, the program lead participants through 12 consecutive self-help modules. The intervention makes use of common CBT-techniques (e.g. activation, cognitive restructuring) as well as elements of positive psychology, emotion-focused therapy, and dream work. The text message-based intervention *MIND-S* ([@bb0395]) aimed to support daily mindfulness practice for depressive symptoms in former psychiatric inpatients (76.2% major depression diagnosis). Over 4 months, participants were asked to regularly indicate the type and duration of mindfulness exercises and received a pre-formulated, automated reinforcing feedback.

### 3.3.3. Transdiagnostic interventions {#s0090}

The search yield seven studies with a transdiagnostic approach ([@bb0070]; [@bb0135]; [@bb0485]; [@bb0620]; [@bb0660]; [@bb0690]; [@bb0695]). Of these, three studies excluded individuals with acute suicidality, alcohol or drug addiction or psychiatric disorders ([@bb0485]; [@bb0135]; [@bb0660]; [@bb0695]) and another study excluding eating and personality disorders ([@bb0070]).

The web-based self-help *GSA-ONLINE* ([@bb0690]) aimed to promote long-term workability following inpatient rehabilitation and was based on a psychodynamic (supportive-expressive) rationale. In a weekly expressive writing task, participants were asked to reflected recurrent, maladaptive relationship patterns at their workplace following Luborsky\'s Core Conflictual Relationship Theme ([@bb0425]) and received an individual feedback from an online-coach. The same study group investigated the web-based program *KEN* ([@bb0695]) that adapted the self-help book 'Living Like You Mean It' ([@bb0190]). Based on the psychodynamic model of affect phobia ([@bb0440]) and mindfulness-based-therapy, the 10-week intervention included consecutive information and exercises on enhancing emotional awareness, regulating anxiety, and experiencing and expressing emotions to other people mindfully. Participants received a weekly, supportive feedback on their exercise completion.

The unguided Finish intervention *MOBILE.NET* by [@bb0620] makes use of principles of self-determination theory ([@bb0110]) to prevent rehospitalization and to increase the quality of life in schizophrenic patients (40% of study participants) and other psychiatric disorders. Over the course of 12 months, participants received pre-selected short messages supporting treatment adherence and self-management strategies. Contents and frequency of messages were selected a-priori by participants.

The CBT-based program *TIMT* by [@bb0135] supported the implementation of individual self-management strategies and health goals in patients after psychosomatic rehabilitation. Participants generated a web-based personal development plan (goal setting, implementation strategies and -challenges) and evaluated implementation over the course of 3 months through a weekly web-diary. The program further included weekly peer- and expert feedback referring to diary entries as well as a symptom monitoring and emergency phone contact.

The mobile-based aftercare *E-COACH* by [@bb0070] followed inpatient rehabilitation in patients with dysfunctional occupational expenditure using handheld devices. Based on general psychotherapy ([@bb0210], [@bb0215]), the intervention aimed to promote action competence in functional health behaviors. Participants were asked four times per day to reflect, modify and evaluate modification of current behavior and experiences according to their personal goals. The control group was advised via telephone contact to implement goal-setting and action-planning strategies.

The Dutch program *KNW* by [@bb0660], [@bb0665] is an unguided psychosocial aftercare for cancer survivors that makes use of common CBT and problem-solving therapy (PST) tools such as problem identification, goal setting, action planning and monitoring behavioral changes. Informative contents of the eight modules were tailored and focused on self-management training regarding residual symptoms (fatigue, depression, anxiety), healthy lifestyle, social and occupational aspects. Modules could be used in a self-determined order following personal recommendations based on self-report data.

The 14-week guided intervention *U-CARE* ([@bb0485]) was offered as a tailored web- or mobile-based program for comorbid symptoms of depression and anxiety in patients after myocardial infarction including psychoeducation, assignments (e.g. self-monitoring, skills training, exercises) followed by a written therapist feedback.

3.4. Quality assessment {#s0095}
-----------------------

Detailed ratings of the risk of bias domains for each study are listed in [Table 2](#t0010){ref-type="table"}. Random sequence generation was met in *n* = 12 studies and rated as high risk of bias in one study ([@bb0555]) and as unclear in three studies ([@bb0175]; [@bb0220]; [@bb0070]). Allocation concealment was mostly fulfilled (*n* = 12) with two studies that were categorized as unclear ([@bb0070]; [@bb0220]; [@bb0485]) and one study as having a high risk of bias ([@bb0555]). None of the studies met criteria for blinding of participants or personnel, formerly resulting in a high risk of bias. One study by [@bb0660] was rated as unclear. However, since blinding of health care providers/systems or participants concerning treatment allocation is not regularly warranted in psychological interventions, performance and detection bias may be indicated commonly. Twelve studies did not report blinding of outcome assessment. Study dropout rates exceeded acceptable cut-offs in relation to latest available follow-up in 9 out of 16 included studies. Most studies (*n* = 11) provided ITT-data for primary outcome. However, two studies ([@bb0660]; [@bb0690]) implemented baseline measurement after allocation, which can be considered a methodical constraint of ITT-analyses. Regarding selective outcome reporting, all studies were classified as having a low risk of bias. In terms of other threats to validity, ten studies assessed type and intensity of co-interventions during the course of the study (e.g. medication, outpatient therapy). For the other studies, comparability of groups at baseline could not be determined definitely or showed high risk of bias ([@bb0555]). Since outcome assessments for intervention and control groups were parallel in the majority of included studies (*n* = 14), measurement timing was categorized as low risk of bias except in two studies (unclear): In the study by [@bb0695] the wait-list CG was transformed into the IG and in [@bb0390], timing of follow-up interviews varied with intervention completion and participants were censored. Intervention compliance was determined acceptable in eight studies. Risk of bias was rated high in six studies with exceeding dropout rates and as unclear in two studies ([@bb0045]; [@bb0620])Table 2Risk of bias assessment (+ low risk of bias; − high risk of bias;? unclear risk of bias).Table 2StudySelection biasPerformance and detection biasAttrition biasReporting biasOther sources of biasRandom sequence generation[a](#tf0095){ref-type="table-fn"}Allocation con-cealment[b](#tf0100){ref-type="table-fn"}Blinding: Participants[c](#tf0105){ref-type="table-fn"}Blinding: Personnel[d](#tf0110){ref-type="table-fn"}Blinding: Outcome assessment[e](#tf0115){ref-type="table-fn"}Dropout[f](#tf0120){ref-type="table-fn"}ITT[g](#tf0125){ref-type="table-fn"}Selective reporting[h](#tf0130){ref-type="table-fn"}Co-interventions[i](#tf0135){ref-type="table-fn"}Similar Groups[j](#tf0140){ref-type="table-fn"}Compliance[k](#tf0145){ref-type="table-fn"}Timing[l](#tf0150){ref-type="table-fn"}[@bb0045][m](#tf0155){ref-type="table-fn"}++----?+++++?+[@bb0690]++−−−−++++−?[@bb0070]??----−−−+++++[@bb0135]++--−−−++++++[@bb0175][n](#tf0160){ref-type="table-fn"}?+--−++−+++++[@bb0220]??--−−−−++?--+[@bb0280][o](#tf0165){ref-type="table-fn"}++--−?+++−?++[@bb0310]++−−+−++++++[@bb0390]++−−+++++?+?[@bb0395]++−−−+−+−−−+[@bb0485]+?−−−+++−?−+[@bb0555]−−−−−−−+−−++[@bb0620]++−−+--[p](#tf0170){ref-type="table-fn"}+++??+[@bb0660][q](#tf0175){ref-type="table-fn"}++−?−++[r](#tf0180){ref-type="table-fn"}, [s](#tf0185){ref-type="table-fn"}+−+--+[@bb0690]++−−−−+[s](#tf0185){ref-type="table-fn"}+−+++[@bb0700]++−−−−+++?−+[^19][^20][^21][^22][^23][^24][^25][^26][^27][^28][^29][^30][^31][^32][^33][^34][^35][^36][^37]

3.5. Effects of the interventions {#s0100}
---------------------------------

### 3.5.1. Symptom severity {#s0105}

The effects of the interventions on the main outcomes of each included study at the study\'s primary endpoint are presented in [Table 3](#t0015){ref-type="table"}. Evidence of clinical symptom severity was reported in 14 studies. Studies yielded small to medium sized post-treatment between-group effects of symptom severity (*d* = −0.08--*d* = −0.45) for the intervention under study. One study investigating an unguided mobile-based self-help yielded contrary results in favor of the CG ([@bb0070]). Small effect sizes could be observed in studies, in which depressive symptoms were measured for a medium follow-up period (6--12 months) in guided, web-based interventions ranging from *d* = −0.03 to *d* = −0.37([@bb0135]; [@bb0280]; [@bb0690]). For the same studies effects for self-rated symptom severity of anxiety varied between *d* = 0.05 and *d* = −0.35 (medium follow-up period).Table 3Main outcomes of studies on Internet-or mobile-based interventions for mental health problems.Table 3StudyHealth conditionComparisonMain outcome \[Instrument\]Outcome[a](#tf0190){ref-type="table-fn"} \[follow-up\][b](#tf0195){ref-type="table-fn"}95% CI[@bb0045]Bulimia NervosaGuided text messaging intervention vs. TAURemission rates \[LIFE\]*RR* = 1.42[c](#tf0200){ref-type="table-fn"}\
\[8 months\]0.99; 2.02[@bb0175]Anorexia Nervosa (AN)Internet-based guided self- help vs. TAUBody Mass Index \[BMI\]*d* = −0.19[d](#tf0205){ref-type="table-fn"}\
\[9 months\]−0.08; 0.46[@bb0220]Bulimia Nervosa/EDNOSInternet-based guided self-help vs. TAUSeverity of eating disorder \[EDE-Q\]*d* = −0.28[d](#tf0205){ref-type="table-fn"}\
\[4 months\]−0.73; 0.18[@bb0310]Bulimia Nervosa (BN)Internet-based guided self- help vs. TAUabstinence from core symptoms of BN\
\[SIAB-EX\]*OR* = 1.29\
\[9 months\]\
\
*OR* = 1.49\
\[18 months\]0.68; 2.44\
\
\
0.77; − 2.86[@bb0280]DepressionInternet-based guided self- help vs. TAURelapse rates \[SCID\]*RR* = 0.28\
\[6 months\]\
\
*RR* = 0.24\
\[24 months\][e](#tf0210){ref-type="table-fn"}0.10; 0.77\
\
\
0.10; 0.55[@bb0390]Recurrent depressionInternet-based guided intervention vs. unguided intervention vs. TAUTransition from to 'well' to 'unwell' \[LIFE\]unguided:\
*RR* = 0.91\
\[12 months\]\
\
*RR* = 0.69\
\[24 months\]\
\
guided:\
*RR* = 1.11\
\[12 months\]\
\
*RR* = 0.92\
\[24 months\]\
0.51; 1.64\
\
\
0.44; 1.09\
\
\
0.63; 1.95\
\
\
\
0.59; 1.43[@bb0395]DepressionText message self-help vs. TAUSeverity of depressive symptoms\
\[PHQ-9\]*d* = −0.45\
\[4 months\]−1.11; −0.23[@bb0485]Myocardial\
Infarction (comorbid depressive/anxiety symptoms)Web-based guided self- help vs. TAUSeverity of depression and anxiety \[HADS-T\]*d* = −0.13\
\[14 weeks\]−0.38; 0.13[@bb0555]DepressionMobile-based self-help vs. TAUSeverity of depression symptoms \[BDI\]*d* = −0.08\
\[3 months\]−0.49; 0.33[@bb0690]DepressionWeb-based self-help vs. attention control websitedepressive symptoms \[BDI-II\]*d* = −0.44\
\[6 months\]−0.71; −0.17[@bb0070]TransdiagnosticMobile-based self-help vs. phone contactWork-related Behaviour and Experience\
Patterns\
\[AVEM\]*d* = 0.18\
\[6 months\]\
\
*d* = 0.08\
\[12 months\]−0.21; 0.56\
\
\
−0.32; 0.48[@bb0135]TransdiagnosticWeb-based guided self- help vs. TAUgeneral psychopathological symptom\
severity\
\[HEALTH-49\]*d* = −0.38[c](#tf0200){ref-type="table-fn"}\
\[3 months\]\
\
*d* = −0.44[c](#tf0200){ref-type="table-fn"}\
\[12 months\]−0.18; −0.58\
\
\
−0.64; −0.24[@bb0620]TransdiagnosticText message self-help vs. TAUpatient readmission to psychiatric\
hospital\
\[Finnish national Care Register for Health Care (HILMO)\]*RR* = 1.11\
\[12 months\]0.92; 1.33[@bb0660]Cancer (transdiagnostic)Web-based self-help vs. WLCG+TAUVarious, e.g. depression \[PHQ-9\]*d* = −0.21\
\[6 months\]\
\
*d* = −0.10\
\[12 months\][f](#tf0215){ref-type="table-fn"}−0.40; −0.01\
\
\
−0.30; 0.11[@bb0695]TransdiagnosticWeb-based guided self-help vs. WLCGVarious, e.g. depression \[PHQ-9\]*d* = −0.34[c](#tf0200){ref-type="table-fn"}\
\[10 weeks\]−0.81; 0.14[@bb0690]TransdiagnosticWeb-based guided self-help vs. TAUsubjective prognosis of work ability \[SPE\]*d* = −0.13\
\[3 months\]\
\
*d* = −0.20\
\[12 months\]−0.28; 0.03\
\
\
−0.36; −0.04[^38][^39][^40][^41][^42][^43][^44][^45]

### 3.5.2. Relapse and rehospitalization {#s0110}

Data on relapse rates were reported by three studies with various target disorders ([@bb0045]; [@bb0280]; [@bb0390]). Relapse rates ranged from 10.5% to 43.0% in the interventions under study for a medium follow-up period. Risk ratios were heterogeneous and included positive effect of interventions in contrast to the control groups ([@bb0045]; [@bb0280]), whereas the web-based intervention for recurrent depression by [@bb0390] reported an elevated risk of relapse in the IG (*RR* = 1.02) at a twelve month follow-up. Rehospitalization rates were reported in five studies ([@bb0175]; [@bb0220]; [@bb0310]; [@bb0390]; [@bb0620]). Results were inconsistent in studies targeting eating disorders: [@bb0220] found a reduced risk of rehospitalization (*RR* = 0.12) at a 4-months follow-up for adults with BN or EDNOS. In contrast, age-stratified data on AN by [@bb0175] showed higher rehospitalization rates for participants in the IG (*RR* = 1.55) at a 9-month follow-up. The transdiagnostic intervention by [@bb0620] showed higher rates of rehospitalization in of participants receiving a mobile-based self-help (*RR* = 1.11), whereas [@bb0390] yielded a lower risk of rehospitalization in the intervention group (*RR* = 0.79). Rehospitalization rates in the study of [@bb0310] were similar in both groups after 18 months. See [Table 3](#t0015){ref-type="table"} for studies investigating relapse and rehospitalization rates as main outcomes.

### 3.5.3. Quality of life and functioning {#s0115}

Quality of life was assessed as a secondary outcome in five studies ([@bb0280]; [@bb0620]; [@bb0660]; [@bb0695]; [@bb0700]) using different self-administered instruments (WHOQOL-BREF, Q-LES-Q, EUROHIS-QOL, QLQ-C30). [@bb0620] reported a null-effect of an unguided mobile-based intervention on quality at a 12-months follow-up. Similarly, [@bb0280] yielded no effect of a web-based CBT for recurrent depression in the short follow-up period. However, the authors could show that effect sizes slightly improved (*d* = 0.0--*d* = −0.20) in the course of 24 months follow-up measurements ([@bb0285]). Other effect sizes for a medium follow-up period were small (*d* = 0.08 to *d* = −0.35), indicating a minor improvement in quality of life through web-based interventions.

Various domains of functioning (e.g. psychological, social, emotional, health-related, occupational) were assessed with self-rated (SF-12, QLQ-C30) and one clinician-rated instrument (GAS) in three studies ([@bb0620]; [@bb0660]; [@bb0690]). Effect sizes were small to medium (*d* = −0.08 to *d* = −0.43), indicating a beneficial effect on functioning of IMIs in the post-discharge phase over control conditions. Interestingly, [@bb0620] could demonstrate, that participants receiving a mobile-based intervention were less disabled than control participants at hospital readmission (Odd\'s Ratio, *OR* = 0.68, 95% CI \[0.47; 0.97\]). However, due to the considerable heterogeneity of operationalization and measurement, meta-analytic pooling of effect sizes was not feasible for other study outcomes.

### 3.5.4. Additional findings {#s0120}

None of the included RCTs explicitly reported data on adherence to pretreatment (e.g. medication compliance). None of the four predominantly mobile-based interventions yielded significant results for the efficacy of the respective intervention, with small effect sizes for studies investigating primarily symptom severity (*d* = −0.08--*d* = −0.45) ([@bb0070]; [@bb0395]; [@bb0555]) and increased risk ratios in trials on relapse prevention (*RR* = 1.11--*RR* = 1.42) ([@bb0045]; [@bb0620]). With regard to human guidance, only two out of five studies using unguided interventions yielded significant results with small to medium effect sizes for a medium follow-up period (*d* = −0.21--*d* = −0.44) ([@bb0660]; [@bb0700]).

### 3.5.5. Cumulated quality of evidence (GRADE) {#s0125}

Confidence in the cumulative quality of evidence per outcome was rated using GRADE ([@bb0230]), see [Appendix C](#ec0015){ref-type="supplementary-material"}. Ratings indicated a moderate cumulated quality of evidence for symptom severity of depression and anxiety. However, the quality of evidence for other inspected outcomes such as quality of life and level of functioning was rated as 'low' and as 'very low' for relapse and rehospitalization rates. Main reasons for downgrading included the indirectness of results (e.g. heterogeneous target disorders), imprecision (e.g. small number of studies, low median sample size) and methodological risk of bias (see [Table 2](#t0010){ref-type="table"}). With regard to outcomes regarding relapse/rehospitalization rates and quality of life, study results were partially inconsistent. The estimation of mean effect sizes was not feasible for the majority of outcomes. Furthermore, possible publication biases could not be estimated, due to the limited number of studies.

3.6. Ongoing trials {#s0130}
-------------------

A search for ongoing trials was conducted in the ICTRP database. The search yielded 718 records of 700 trials (years 2003--2018), of which *n* = 24 were identified as potentially relevant. Targeted conditions were mostly affective disorders or comorbid mental symptoms in somatic conditions (cancer, osteoarthritis, diabetes, cardiac disease). However, the majority (*n* = 12) described interventions adjunct to primary care (ISRCTN56908625, [NCT03404583](NCT03404583){#ir0005}), as standalone interventions for mental disorders (ISRCTN64953693) or for comorbid mental disorders of serious somatic disorders (ACTRN12613001198718, ACTRN12613001174774, ISRCTN45945396, NTR793, ACTRN12613001026718, ACTRN12613000001796, ACTRN12613001170718, ACTRN12611000278932, ISRCTN32477700) that did not classify as aftercare or follow-up interventions. The main publications of four of these were included in this review included in this review ([@bb0135]; [@bb0175]; [@bb0620]; [@bb0695]; [@bb0700]). Seven studies that planned to investigate web- or mobile-based aftercare for various mental disorders (affective, eating disorders, cancer-related anxiety/depression) and were still ongoing or unpublished (ISRCTN32477700; DRKS00008847; DRKS00009272; [NCT02258711](NCT02258711){#ir0010}; ISRCTN18274621; ISRCTN08870215; NTR2599) or a pilot study not fulfilling the criteria of RCT (ACTRN12617001447347) at the time of the systematic search.

4. Discussion {#s0135}
=============

4.1. Summary of evidence {#s0140}
------------------------

This review is the first to systematically summarize and examine the existing empirical evidence of Internet- and mobile-based aftercare and follow-up interventions for the tertiary prevention of a broad range of mental disorders and related symptoms. It therefore adds to previous reviews on primary prevention ([@bb0145]; [@bb0550]) and provides a comprehensive overview of modern instruments of continuous care of mental disorders.

Sixteen RCTs were included in this review, all of them were published within the last six years. The selected studies corroborate previous research, highlighting that the implementation of IMIs is mostly web-based, that CBT-techniques are more common than other therapeutic interventions and that some form of asynchronous guidance is frequently used ([@bb0055]; [@bb0145]; [@bb0550]). In this regard, studies comprised mainly minimal guidance, which has been shown to be a (cost-) effective strategy in most mental disorders ([@bb0055]; [@bb0480]). Mirroring the frequent comorbidity and commonalities of mental disorders ([@bb0355]; [@bb0360]), most studies were designed transdiagnostic, targeting occupational rehabilitation ([@bb0070]; [@bb0690]), individual self-management strategies ([@bb0135]; [@bb0620]) or comorbid mental symptoms of severe somatic diseases ([@bb0485]; [@bb0660]). Disorder-specific interventions targeted affective and eating disorders, reflecting their frequent recurrences and risk of chronification ([@bb0350]; [@bb0445]).

The limited amount of studies eligible for inclusion did not allow to draw conclusions about the efficacy of IMIs as aftercare or follow-up interventions for mental disorders. Small effects were found for depressive and symptoms of anxiety in guided, web-based interventions. However, considering that tertiary prevention aims to sustain health and functioning and thus treatment gains of previous (main) interventions, smaller effect sizes can be expected and are consequently lower than moderate to high effect sizes observed in IMIs for in the context of the treatment of (full-blown) mental disorders ([@bb0385]). The small effects found for symptom severity can be compared to findings from [@bb0550], showing a small effect of IMIs in the treatment of subclinical depressive symptoms (*n* = 8, *SMD* = −0.22). Also, since the included studies did not target anxiety disorders explicitly, our findings corroborate previous research, showing small effects of IMIs on subclinical anxiety ([@bb0240]; [@bb0540]). Furthermore, some of the interventions included in our meta-analyses primarily aimed to prevent relapse or rehospitalization ([@bb0045]; [@bb0175]; [@bb0280]), which may further explain small effects on symptom severity as a secondary outcome measure. In summary, the meta-analytic results must be interpreted cautiously considering various sources of heterogeneity (e.g. target mental disorders, intervention characteristics, methodological limitations). Nevertheless, the present findings illustrate the potential of IMIs in the field of tertiary prevention as aftercare and follow-up in maintaining treatment gains of depressive and anxiety symptoms.

Study results on relapse and rehospitalization rates were inconsistent, including reduced risk ratios for interventions targeting eating disorders or recurrent depression ([@bb0045]; [@bb0220]; [@bb0280]; [@bb0390]) in contrast to studies reporting similar or elevated risk of relapse and rehospitalization between experimental groups ([@bb0175]; [@bb0390]; [@bb0620]). However, as continuous care improves the detection of early warnings signs of recurrence, rehospitalization can also be seen as an indicator of an early and adequate treatment initiation. Further research is needed, to explore the potential of IMIs in accelerated care and establish the effectiveness if IMIs in relapse prevention in relevant mental disorders.

Included studies reported mixed evidence of the efficacy of IMIs on quality of life and functioning, including nearly zero ([@bb0280]; [@bb0620]) to medium effect sizes ([@bb0695]; [@bb0700]). From a methodical point of view, multidimensional and complex measures of quality of life may be less accurate and responsive than symptom- or disorder-specific outcome measures, in particular when the latter is the primary outcome of a treatment ([@bb0275]). Also, the course of quality of life or functioning may be more discontinuous in comparison to clinical change, due to various adaption processes in the immediate post-discharge phase. Results by [@bb0285] support the and delayed effect of IMIs on quality of life. Future research thus should include adequately powered sample sizes and long-term follow-up periods to determine the effectiveness of IMIs on quality of life and functioning.

Moreover, our results indicate a limited effectiveness of unguided predominantly mobile-based interventions as aftercare. This corroborates previous research, demonstrating a beneficial effect of guidance on adherence and effectiveness ([@bb0055]; [@bb0480]). Although automated mobile-based interventions can be easily implemented as low-intensity maintenance interventions, future research should aim to expand their potential in the post-discharge phase.

4.2. Methodological quality of studies {#s0145}
--------------------------------------

Methodological quality of included studies was suboptimal in total, as reflected in mostly low-quality GRADE ratings ([@bb0230]) with moderate quality of evidence only for symptom severity of depression. Several methodical shortcomings and consequent recommendations for future studies can be outlined: Firstly, as expected, no study met quality criteria of blinding of personnel and participants, which may be considered as inevitable in psychological trials. However, we identified multiple studies without proper blinding of outcome assessors, demonstrating abundant room for methodical improvement in future studies. Secondly, we observed critical treatment fidelity (dropout rates, intervention adherence) in about two-thirds of the studies. However, average dropout rates of guided (31.6%) and unguided (34.7%) interventions are comparable to evidence from previous meta-analyses ([@bb0455]; [@bb0535]; [@bb0625]). We could not observe a definite cause for reduced treatment fidelity. Previous research indicates that treatment fidelity is influenced by various factors, including study design (e.g. amount of guidance, intervention duration), intervention characteristics (e.g. interactivity, adaptability, usability), as well as user- or contextual characteristics (e.g. symptom severity, treatment credibility, co-interventions) ([@bb0010]; [@bb0055]; [@bb0125]; [@bb0345]). Additionally, reduced treatment fidelity in various instruments of tertiary prevention has been documented previously ([@bb0380]; [@bb0460]). In this regard, reduced treatment adherence is not only an indicator for limited effectiveness or feasibility, but can also express recovery, since participants do not necessarily need to complete all intervention parts to benefit from treatments. Future studies are thus advised to differentiate reasons for and timing of reduced adherence or attrition, to better predict and prevent dropout in IMIs.

Thirdly, assessment of type and frequency of co-interventions was often missing or limited to the assessment of medication prescription. For three studies, differentiated reports on type and intensity of co-interventions were available ([@bb0050]; [@bb0390]; [@bb0620]). [@bb0050] for example could demonstrate that the relapse risk for BN in participants of the IG (mobile-based intervention) was slightly lower for those, who exclusively used the intervention (24.2%) than for the combination with outpatient therapy (28.9%). Similar results have been documented by for therapist-guided chat groups in relapse prevention of BN ([@bb0040]). These controversial findings underline the need for further studies to determine the differentiated indication for IMIs in terms of stepped or continuous care research on moderators of their effectiveness in routine care. Fourthly, CONSORT-standards regarding the inclusion of ITT-analyses were not evident in all the included studies, increasing the risk of biased results and thus limiting interpretability of study results. Therefore, future studies should include ITT-analyses and report type, amount and methods for handling of missing data ([@bb0570]).

4.3. Limitations {#s0150}
----------------

Firstly, we did not limit our review to certain mental disorders, to illustrate the diversity of interventions in the field of tertiary prevention. Consequently, we included a broad spectrum of mental disorders, as reflected by the majority of transdiagnostic interventions. Furthermore, interventions differed regarding study objectives (e.g. relapse prevention, symptom reduction, occupational integration), therapeutic rationales, design, and mode of guidance. Also, type (e.g. self- or clinician-rated) and timing of measurement, as well as the choice of comparators, varied across studies. In this regard, some studies implemented waiting list CGs, others different types of active control groups (e.g. face-to-face treatment, placebo website). Therefore, subsequent heterogeneity must be considered carefully. Although the limited amount of studies eligible for inclusion did not allow for robust conclusions about the efficacy of IMIs as aftercare or follow-up interventions for mental health issues, our specific inclusion criteria (see 2.2) yielded a meaningful study selection. However, this review\'s focus on the transition phase after acute treatment does not allow to generalize the effectiveness of included IMIs to the entire field of tertiary prevention. Beyond step-down interventions, this may include long-term disease management or instruments focusing on the reduction of disability. Particularly for mental disorders with high risk for chronic courses IMIs may accompany existing medical strategies as low-threshold and flexible instruments.

Above that, the existence of a publication bias needs to be considered as a major concern in social sciences ([@bb0105]; [@bb0545]). We could not examine possible publication bias with elaborated statistical methods (e.g. funnel plots), due to the limited number of studies and considerable heterogeneity ([@bb0605]).

4.4. Practical implications and future research {#s0155}
-----------------------------------------------

Although a growing body of research illustrates the feasibility and effectiveness of IMIs for various mental disorders, this review reveals important directions for future research and necessary efforts in clinical implementation.

### 4.4.1. Tertiary prevention of psychiatric and chronic mental disorders {#s0160}

Our search yielded a broad spectrum of target disorders of IMIs in tertiary prevention, particularly addressing multiple disorders through transdiagnostic interventions. Trials investigating web- or mobile-based aftercare for further mental disorders that are characterized by chronic courses such as psychiatric, somatoform or personality disorders were underrepresented in our search results. However, a growing body of research recognizes the applicability of IMIs in the tertiary prevention of severe or chronic mental disorders. A recent review by [@bb0655] documents the potential of IMIs in preventing relapse in schizophrenic disorders, e.g. in promoting adherence to medical treatment using mobile-based symptom monitoring and automated notification of practitioners ([@bb0465]; [@bb0595]). Yet, there is still abundant room for the implementation of psychosocial intervention elements in IMIs in the field of tertiary prevention of psychiatric disorders or severe clinical conditions such as suicidality ([@bb0100]). For instance, the study by [@bb0620] examined a low-intensity, mobile-based self-help to promote self-management strategies in a psychiatric target population but could not demonstrate its effectiveness with regard to recurrence or quality of life in contrast to usual care. For chronic depression, a study by [@bb0290] provides positive evidence for a web-based intervention adjunct to standard community care in symptom and relapse reduction. Furthermore, several studies have investigated web- and mobile-based relapse prevention in bipolar disorder ([@bb0025]; [@bb0115]; [@bb0420]; [@bb0590]). However, these studies could not demonstrate a long-term effectiveness of IMIs on functioning or relapse rates in contrast to active or passive control groups. Together, these results highlight the need for further studies addressing the challenges of continuous care in chronic mental disorders. Moreover, since most mental disorders show high incidence rates in childhood and adolescence ([@bb0080]) research on the effectiveness of web- or mobile-based aftercare or intermediate care in this target group represents another promising field of study.

### 4.4.2. Strategies for implementation in routine care {#s0165}

Besides rigorous and large-scaled RCTs, further research is also needed to establish the effectiveness of IMIs in routine care. Previous studies in naturalistic, e.g. community care settings show mixed results ([@bb0095]; [@bb0205]; [@bb0250]; [@bb0435]). Implementation of IMIs would require foremost structural efforts such as sufficient resources in health care systems, clinical guidelines and quality criteria ([@bb0365]; [@bb0525]), a participative approach in the development and integration of IMIs with existing treatments and strategies to facilitate access and reach of IMIs in relevant target groups.

Given the increased access and use of the Internet in health issues ([@bb0165]), IMIs could reach people, that do not access established mental health care but deliberately seek for low-threshold support. Implementation strategies should therefore include multiple contact points and collaboration across healthcare-, education- or occupational- systems and institutions. Also, the possibility for self-reference, which has been associated with elevated adherence and effectiveness ([@bb0315]; [@bb0565]), could facilitate the implementation of IMIs. Another promising approach is the integration of IMIs in existing treatments (blended-care), where certain treatment elements (e.g. psychoeducation, exercises) can be augmented with or transferred to a web- or mobile-based application ([@bb0170]). A meta-analysis of 25 studies by [@bb0410] found positive evidence that mobile-based interventions could boost the effect of primary psychotherapy. Blended-care may also help to concentrate therapeutic resources or to promote adherence and self-efficacy in patients. An innovative design is reported in the study by [@bb0700] who combined blended- and aftercare and proved the effectiveness of a web-based intervention for the reduction of depression. [@bb0015] found that adding a 3-week, web-based booster program to a ten-week iCBT for patients with obsessive-compulsive disorder (OCD) could further improve the long-term outcome and prevent relapse. This may also point to a beneficial application of IMIs as aftercare or intermediate care following outpatient psychotherapy.

Regarding individual barriers to access and adoption of IMIs, previous studies have shown limited acceptance of IMIs in the general population ([@bb0165]; [@bb0225]), in various patient groups ([@bb0255]; [@bb0650]) or in health professionals ([@bb0260]). Person-centered barriers to acceptance include negative expectations towards outcome and usability, unfavorable attitudes of the social environment, as well as limited knowledgeability and eHealth literacy ([@bb0255], [@bb0260], [@bb0265]). Recent studies provide promising evidence that brief video-based presentations about areas of application, effectiveness, data security or utilization, combined with first hands-on experience can be an economical way to facilitate acceptance ([@bb0060]; [@bb0140]). This would imply the systematic measurement of barriers to access and acceptance of IMIs. Promising instruments include the assessment of eHealth literacy ([@bb0490]; [@bb0630]) or attitudes towards psychological IMIs ([@bb0560]). However, the identification and facilitation of acceptance need to be expanded to health professionals ([@bb0130]) and other stakeholders in the healthcare system ([@bb0610]).

### 4.4.3. Outcome assessment and research design {#s0170}

Considering the importance of participatory approaches in improving the adoption and impact of IMIs in health care ([@bb0635]; [@bb0675]), patient-relevant outcomes are an important indicator of the practical and clinical relevance of IMIs. However, only half of the studies included in this review reported outcomes related to quality of life or functioning. Missing information on post-intervention employment status can be seen as critical as well. Future studies should thus cover relevant domains of functioning.

Furthermore, systematic assessment of cost-effectiveness is highly relevant for public health policy in order to compare the savings of IMIs in comparison with costs related to traditional health care utilization (e.g. rehospitalization), work loss or mortality. Of the included studies, only two ([@bb0290]; [@bb0620]) included instruments for economic evaluation and demonstrated a relative cost-effectiveness in contrast to the control group. Cost-effectiveness also relates to intervention design, where previous research has documented the superiority of guided in comparison to unguided IMIs ([@bb0120]), while on a public health level, low-maintenance interventions may be associated with a higher range and effect in relation to the population level. More research is needed to differentiate moderators of cost-effectiveness in different healthcare settings.

### 4.4.4. Making use of technological innovations {#s0175}

Although this review found a broad spectrum of mostly web- and less frequently used mobile-based interventions, it seems, that the technological potential of IMIs is not yet sufficiently used. Since web- and mobile technologies advance rapidly, research on IMIs may benefit from technical progress in various domains. In future, advances in machine learning and intelligent algorithms may add to the development of more elaborated and tailored intervention strategies such as just-in-time interventions ([@bb0475]), artificial intelligence in guidance and interaction or red flag systems that may identify treatment loss or failure and adapt intervention content accordingly. IMIs may also benefit from the increasing availability of sensor data (e.g. activity, health, context data) through smartphones, wearables or other devices that could be used to refine and adapt intervention strategies to various context and risk variables ([@bb0615]). Therefore, it is likely that tailored- or adaptive IMIs will add substantially to the progress and implementation of personalized medicine. However, elevated intervention flexibility and complexity would initially increase development costs and expense. Thus, the superiority of tailored IMIs in contrast to standardized or generic interventions remains to be investigated.

4.5. Conclusion {#s0180}
---------------

This review provides researchers, clinicians and public health policymakers with a valuable overview of the current state of research on the efficacy and clinical feasibility of IMIs as aftercare or follow-up interventions of mental disorders. IMIs can be effective instruments in maintaining treatment gains in the post-discharge phase. Despite small effects on clinical outcomes such as symptom severity, the flexibility, high range and facilitated monitoring in IMIs in relation to conventional aftercare are promising qualities for routine care. However, the current evidence regarding symptom severity, relapse prevention or quality of life is mixed, demonstrating the need of further, high-quality, large-scale RCTs to establish a solid evidence base for the effects of IMIs in tertiary prevention. Above that, future research should broaden the range of targeted mental disorders and also include severe and chronic conditions. Further efforts are needed regarding treatment adherence and identifying of critical courses in the vulnerable post-discharge phase. Advancements in machine-based learning and mobile-based technologies can improve adaptability and tailoring of interventions. Eventually, effective and feasible IMIs need to be implemented into routine care settings to make them impactful to people\'s lives.
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